Curi Bio
Pre-clinicalCuri Bio develops human-relevant platforms integrating human cells, systems, and data to accelerate the discovery of new medicines. Curi’s human iPSC-based products and services enable scientists to build mature and predictive human iPSC-derived tissues—with a focus on cardiac, musculoskeletal, and
Founded
2015
Focus
Nanotechnology
About
Curi Bio develops human-relevant platforms integrating human cells, systems, and data to accelerate the discovery of new medicines. Curi’s human iPSC-based products and services enable scientists to build mature and predictive human iPSC-derived tissues—with a focus on cardiac, musculoskeletal, and
Funding History
2Total raised: $18.2M
Series A$15MDigitalis VenturesJan 15, 2022
Seed$3.2MUndisclosedFeb 15, 2020
Company Info
TypePrivate
Founded2015
LocationSeattle, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile